Cryoablation Of Early Invasive Ductal Breast Cancer With MRI Confirmation Shows Promising Clinical Benefits, According To Study Presented At RSNA

News — By on December 6, 2008 at 1:00 am

Early clinical experience with the FDA cleared Visica 2(TM) Treatment System from Sanarus Medical confirms the effectiveness of ultrasound guided cryoablation to completely eradicate small, unifocal Invasive Ductal Breast Cancer (IDC). Initial data from this multi-center study was presented at the 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), November 29 – December 5, 2008.

Please read the complete article and let us know what you think below.

Leave a Reply

Trackbacks

Leave a Trackback